Thus, its expression in tumor tissue correlated with mutations in CDH1 (p = 0.04), whereas its expression in non-tumor tissues of GC patients was correlated with mutations in TP53 (p = 0.038). This evidence concerns the gene CDH1 and gastric cancer.